2003 Fiscal Year Final Research Report Summary
Heme oxygenases, intrinsic defense system, as a novel therapeutic target for atherosclerotic disorders
Project/Area Number |
14570682
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Circulatory organs internal medicine
|
Research Institution | Fukushima Medical University |
Principal Investigator |
ISHIKAWA Kazunobu Fukushima Medical University, The first internal medicine, Lecturer, 医学部, 講師 (80222959)
|
Co-Investigator(Kenkyū-buntansha) |
YAOITA Hiroyuki Fukushima Medical University, The first internal medicine, Lecturer, 医学部, 講師 (50264544)
MARUYAMA Yukio Fukushima Medical University, The first internal medicine, Professor, 医学部, 教授 (90004712)
|
Project Period (FY) |
2002 – 2003
|
Keywords | heme oxygenase / atherosclerosis / vascular injury / macrophage / oxygen radical / oxidized LDL / vascular endothelial cell |
Research Abstract |
Heme oxygenase (HO), an enzyme essential for heme degradation, shows anti-oxidative and anti-inflammatory properties via the production of bile pigmehts, carbon monoxide (CO) and ferritin induction under various pathophysiological conditions. A number of recent studies have shown biological effects of HO reaction in cardiovascular disorders. An inducible form of HO, H0-1, is induced by a variety of stresses such as oxidized lipoproteins, cytokines, hemodynamic changes, angiotensin II and nitric oxide (NO) in vascular wall. In this grant period, we observed that H0-1 induction seems to function as an adaptive response against these injurious stimuli. H0-1 induction in artery wall scavenged reactive oxygen species, which leads to the attenuation of monocyte adhesion and chemotaxis. H0-1 induction also reduces lipid peroxidation in plasma and artery wall. These properties of H0-1 suggest anti-atherogenic roles of this enzyme. We also examined the roles of endothelial H0-1 expression and bilirubin in atherogenesis. HO-1 also seems to play a significant role in restenosis after angioplasty, which is a major clinical problem associated with atherosclerosis. As a clinical research, we investigated the changes of the levels of biopyrrins in the patients with acute myocardial infarction. human HO-1 genetics supports these experimental results. We are currently continuing the research, which will solve current problems in various cardiovascular disorders.
|
Research Products
(8 results)